top of page

Roche Nears Deal to Buy Spark Therapeutics for Close to $5 Billion

Roche Holding AG RHHBY 0.51% is nearing a deal to buy Philadelphia biotechnology company Spark Therapeutics Inc., according to people familiar with the matter, as the Swiss drugmaker seeks to expand its presence treating hemophilia.

Read the full story here.


Recent Posts

See All
bottom of page